IRMD logo

IRadimed (IRMD) Cash From Financing

Annual CFF

-$14.34 M
-$679.50 K-4.98%

December 31, 2024


Summary


Performance

IRMD Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRMDcash flowmetrics:

Quarterly CFF

-$2.42 M
-$499.20 K-26.02%

December 31, 2024


Summary


Performance

IRMD Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRMDcash flowmetrics:

TTM CFF

-$14.34 M
-$2.15 M-17.69%

December 31, 2024


Summary


Performance

IRMD TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRMDcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

IRMD Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.0%-26.0%-17.7%
3 y3 years-10000.0%-26.0%-17.7%
5 y5 years-809.6%-26.0%-17.7%

IRMD Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%at low-4722.4%+81.8%<-9999.0%at low
5 y5-year-809.6%at low-378.4%+81.8%-809.7%at low
alltimeall time-212.8%at low-119.1%+81.8%-207.9%at low

IRadimed Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
-$14.34 M(+5.0%)
-$2.42 M(+26.0%)
-$14.34 M(+17.7%)
Sep 2024
-
-$1.92 M(-2.1%)
-$12.18 M(+18.3%)
Jun 2024
-
-$1.96 M(-75.6%)
-$10.29 M(+22.2%)
Mar 2024
-
-$8.04 M(+2961.7%)
-$8.42 M(-38.3%)
Dec 2023
-$13.66 M(+7.5%)
-$262.60 K(+736.3%)
-$13.66 M(+0.5%)
Sep 2023
-
-$31.40 K(-65.0%)
-$13.59 M(+0.6%)
Jun 2023
-
-$89.80 K(-99.3%)
-$13.51 M(+0.6%)
Mar 2023
-
-$13.27 M(+6586.5%)
-$13.42 M(+5.7%)
Dec 2022
-$12.71 M(<-9900.0%)
-$198.50 K(-479.5%)
-$12.71 M(+1.6%)
Sep 2022
-
$52.30 K(-1017.5%)
-$12.51 M(+0.0%)
Jun 2022
-
-$5700.00(-100.0%)
-$12.50 M(+0.1%)
Mar 2022
-
-$12.55 M(<-9900.0%)
-$12.49 M(<-9900.0%)
Dec 2021
$24.40 K(-95.3%)
$2200.00(-95.9%)
$24.60 K(-109.6%)
Sep 2021
-
$54.20 K(+1131.8%)
-$255.10 K(-145.6%)
Jun 2021
-
$4400.00(-112.2%)
$558.90 K(+87.6%)
Mar 2021
-
-$36.20 K(-87.0%)
$297.90 K(-43.0%)
Dec 2020
$522.50 K(-74.1%)
-$277.50 K(-132.0%)
$522.40 K(-31.3%)
Sep 2020
-
$868.20 K(-438.3%)
$759.90 K(-52.5%)
Jun 2020
-
-$256.60 K(-236.3%)
$1.60 M(-9.8%)
Mar 2020
-
$188.30 K(-570.8%)
$1.77 M(-12.2%)
Dec 2019
$2.02 M(+117.2%)
-$40.00 K(-102.3%)
$2.02 M(+14.0%)
Sep 2019
-
$1.71 M(-2178.0%)
$1.77 M(+66.8%)
Jun 2019
-
-$82.20 K(-118.9%)
$1.06 M(-16.5%)
Mar 2019
-
$434.20 K(-250.6%)
$1.27 M(+36.9%)
DateAnnualQuarterlyTTM
Dec 2018
$929.90 K(-148.9%)
-$288.30 K(-128.9%)
$929.80 K(-17.9%)
Sep 2018
-
$998.70 K(+680.8%)
$1.13 M(-954.3%)
Jun 2018
-
$127.90 K(+39.8%)
-$132.50 K(-92.6%)
Mar 2018
-
$91.50 K(-206.1%)
-$1.80 M(-5.4%)
Dec 2017
-$1.90 M(-79.2%)
-$86.20 K(-67.6%)
-$1.90 M(+9.8%)
Sep 2017
-
-$265.70 K(-82.7%)
-$1.73 M(+64.2%)
Jun 2017
-
-$1.54 M(>+9900.0%)
-$1.05 M(-71.9%)
Mar 2017
-
-$10.90 K(-113.1%)
-$3.75 M(-58.8%)
Dec 2016
-$9.12 M(-492.0%)
$83.20 K(-79.8%)
-$9.12 M(+12.9%)
Sep 2016
-
$411.10 K(-109.7%)
-$8.07 M(+5.6%)
Jun 2016
-
-$4.24 M(-21.2%)
-$7.65 M(+128.1%)
Mar 2016
-
-$5.38 M(-576.9%)
-$3.35 M(-244.2%)
Dec 2015
$2.33 M(-81.7%)
$1.13 M(+34.6%)
$2.33 M(+58.3%)
Sep 2015
-
$837.70 K(+1369.6%)
$1.47 M(-88.9%)
Jun 2015
-
$57.00 K(-81.3%)
$13.28 M(+2.0%)
Mar 2015
-
$304.30 K(+12.6%)
$13.02 M(+2.4%)
Dec 2014
$12.71 M(-2575.6%)
$270.20 K(-97.9%)
$12.71 M(+4.7%)
Sep 2014
-
$12.65 M(-6324.9%)
$12.14 M(-1785.9%)
Jun 2014
-
-$203.20 K(+3125.4%)
-$720.10 K(+38.6%)
Mar 2014
-
-$6300.00(-97.9%)
-$519.60 K(+1.2%)
Dec 2013
-$513.40 K(+115.3%)
-$299.10 K(+41.4%)
-$513.30 K(+139.6%)
Sep 2013
-
-$211.50 K(+7733.3%)
-$214.20 K(+7833.3%)
Jun 2013
-
-$2700.00(<-9900.0%)
-$2700.00(<-9900.0%)
Mar 2013
-
$0.00
$0.00
Dec 2012
-$238.50 K
-
-

FAQ

  • What is IRadimed annual cash flow from financing activities?
  • What is the all time high annual CFF for IRadimed?
  • What is IRadimed annual CFF year-on-year change?
  • What is IRadimed quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for IRadimed?
  • What is IRadimed quarterly CFF year-on-year change?
  • What is IRadimed TTM cash flow from financing activities?
  • What is the all time high TTM CFF for IRadimed?
  • What is IRadimed TTM CFF year-on-year change?

What is IRadimed annual cash flow from financing activities?

The current annual CFF of IRMD is -$14.34 M

What is the all time high annual CFF for IRadimed?

IRadimed all-time high annual cash flow from financing activities is $12.71 M

What is IRadimed annual CFF year-on-year change?

Over the past year, IRMD annual cash flow from financing activities has changed by -$679.50 K (-4.98%)

What is IRadimed quarterly cash flow from financing activities?

The current quarterly CFF of IRMD is -$2.42 M

What is the all time high quarterly CFF for IRadimed?

IRadimed all-time high quarterly cash flow from financing activities is $12.65 M

What is IRadimed quarterly CFF year-on-year change?

Over the past year, IRMD quarterly cash flow from financing activities has changed by -$499.20 K (-26.02%)

What is IRadimed TTM cash flow from financing activities?

The current TTM CFF of IRMD is -$14.34 M

What is the all time high TTM CFF for IRadimed?

IRadimed all-time high TTM cash flow from financing activities is $13.28 M

What is IRadimed TTM CFF year-on-year change?

Over the past year, IRMD TTM cash flow from financing activities has changed by -$2.15 M (-17.69%)